Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01649284
Title Afatinib Expanded Access Program
Recruitment Approved for marketing
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
1200.45.004 Boehringer Ingelheim Investigational Site Mobile Alabama United States Details
1200.45.116 Boehringer Ingelheim Investigational Site Goodyear Arizona United States Details
1200.45.057 Boehringer Ingelheim Investigational Site Hot Springs Arkansas United States Details
1200.45.078 Boehringer Ingelheim Investigational Site Anaheim California United States Details
1200.45.114 Boehringer Ingelheim Investigational Site Burbank California United States Details
1200.45.123 Boehringer Ingelheim Investigational Site Glendale California United States Details
1200.45.115 Boehringer Ingelheim Investigational Site Lakewood California United States Details
1200.45.117 Boehringer Ingelheim Investigational Site Long Beach California United States Details
1200.45.102 Boehringer Ingelheim Investigational Site Monterey California United States Details
1200.45.091 Boehringer Ingelheim Investigational Site Pleasant Hill California United States Details
1200.45.098 Boehringer Ingelheim Investigational Site Pleasant Hill California United States Details
1200.45.006 Boehringer Ingelheim Investigational Site Ranco Cucamonga California United States Details
1200.45.003 Boehringer Ingelheim Investigational Site Southington Connecticut United States Details
1200.45.007 Boehringer Ingelheim Investigational Site Stamford Connecticut United States Details
1200.45.026 Boehringer Ingelheim Investigational Site Hollywood Florida United States Details
1200.45.097 Boehringer Ingelheim Investigational Site Hollywood Florida United States Details
1200.45.017 Boehringer Ingelheim Investigational Site Jacksonville Florida United States Details
1200.45.058 Boehringer Ingelheim Investigational Site Jacksonville Florida United States Details
1200.45.016 Boehringer Ingelheim Investigational Site Lakeland Florida United States Details
1200.45.103 Boehringer Ingelheim Investigational Site Miami Beach Florida United States Details
1200.45.037 Boehringer Ingelheim Investigational Site Orlando Florida United States Details
1200.45.056 Boehringer Ingelheim Investigational Site Port St. Lucie Florida United States Details
1200.45.119 Boehringer Ingelheim Investigational Site Titusville Florida United States Details
1200.45.095 Boehringer Ingelheim Investigational Site Alpharetta Georgia United States Details
1200.45.029 Boehringer Ingelheim Investigational Site Athens Georgia United States Details
1200.45.042 Boehringer Ingelheim Investigational Site Macon Georgia United States Details
1200.45.121 Boehringer Ingelheim Investigational Site Valdosta Georgia United States Details
1200.45.024 Boehringer Ingelheim Investigational Site Decatur Illinois United States Details
1200.45.009 Boehringer Ingelheim Investigational Site Evanston Illinois United States Details
1200.45.099 Boehringer Ingelheim Investigational Site Peoria Illinois United States Details
1200.45.040 Boehringer Ingelheim Investigational Site Waterloo Iowa United States Details
1200.45.041 Boehringer Ingelheim Investigational Site Wichita Kansas United States Details
1200.45.083 Boehringer Ingelheim Investigational Site Marrero Louisiana United States Details
1200.45.087 Boehringer Ingelheim Investigational Site Metairie Louisiana United States Details
1200.45.019 Boehringer Ingelheim Investigational Site Columbia Maryland United States Details
1200.45.039 Boehringer Ingelheim Investigational Site Rockville Maryland United States Details
1200.45.053 Boehringer Ingelheim Investigational Site Ann Arbor Michigan United States Details
1200.45.046 Boehringer Ingelheim Investigational Site Detroit Michigan United States Details
1200.45.100 Boehringer Ingelheim Investigational Site Jackson Mississippi United States Details
1200.45.067 Boehringer Ingelheim Investigational Site St. Louis Missouri United States Details
1200.45.071 Boehringer Ingelheim Investigational Site Billings Montana United States Details
1200.45.021 Boehringer Ingelheim Investigational Site Omaha Nebraska United States Details
1200.45.066 Boehringer Ingelheim Investigational Site Freehold New Jersey United States Details
1200.45.105 Boehringer Ingelheim Investigational Site Albuquerque New Mexico United States Details
1200.45.080 Boehringer Ingelheim Investigational Site Brooklyn New York United States Details
1200.45.068 Boehringer Ingelheim Investigational Site Fresh Meadows New York United States Details
1200.45.051 Boehringer Ingelheim Investigational Site New York New York United States Details
1200.45.092 Boehringer Ingelheim Investigational Site New York New York United States Details
1200.45.001 Boehringer Ingelheim Investigational Site Charlotte North Carolina United States Details
1200.45.086 Boehringer Ingelheim Investigational Site Bismarck North Dakota United States Details
1200.45.048 Boehringer Ingelheim Investigational Site Minot North Dakota United States Details
1200.45.090 Boehringer Ingelheim Investigational Site Canton Ohio United States Details
1200.45.005 Boehringer Ingelheim Investigational Site Columbus Ohio United States Details
1200.45.089 Boehringer Ingelheim Investigational Site Tulsa Oklahoma United States Details
1200.45.094 Boehringer Ingelheim Investigational Site Portland Oregon United States Details
1200.45.020 Boehringer Ingelheim Investigational Site Hershey Pennsylvania United States Details
1200.45.096 Boehringer Ingelheim Investigational Site Johnstown Pennsylvania United States Details
1200.45.060 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania United States Details
1200.45.085 Boehringer Ingelheim Investigational Site Pottstown Pennsylvania United States Details
1200.45.120 Boehringer Ingelheim Investigational Site Rapid City South Dakota United States Details
1200.45.049 Boehringer Ingelheim Investigational Site Cookeville Tennessee United States Details
1200.45.113 Boehringer Ingelheim Investigational Site El Paso Texas United States Details
1200.45.045 Boehringer Ingelheim Investigational Site Fairfax Virginia United States Details
1200.45.076 Boehringer Ingelheim Investigational Site Seattle Washington United States Details
1200.45.093 Boehringer Ingelheim Investigational Site Charleston West Virginia United States Details
1200.45.125 Boehringer Ingelheim Investigational Site Wausau Wisconsin United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field